BTIG Maintains Buy on Xtant Medical Hldgs, Lowers Price Target to $1

Benzinga Newsdesk www.benzinga.com Neutral 51.8%

Neg 0% Neu 51.8% Pos 0%

BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the price target from $1.5 to $1.